© The Financial Times Ltd 2016
FT and 'Financial Times' are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
March 1, 2012 4:25 pm
New York University’s Stern school of business has become the latest US business school to offer a joint business and medical degree, joining forces with the university’s medical school. NYU joins the ranks of universities such as Harvard, Dartmouth, Cornell, Pennsylvania, Duke and its New York neighbour Columbia, all of which teach accelerated MD/MBA programmes.
The growth in MD/MBA programmes in the US has been substantial. In 1993 there were just five such programmes in the US, according to figures from the Association of MD/MBA Programmes (AMMP), while by the beginning of 2012 there were 65.
The growth in such programmes reflects the changing environment for medical practitioners in the US. “A changing healthcare environment increasingly requires physician leaders to manage the business of medicine as part of patient care,” said Peter Henry, dean of NYU Stern. “Our new dual degree programme will provide aspiring physicians with the interdisciplinary perspective, business skills and medical expertise to shape the future of healthcare.”
Students enrolled on the five-year Stern MD/MBA programme begin at NYU School of Medicine on a full-time basis for three years, then spend the summer of the third year and the spring semester of the fourth year at Stern to pursue MBA coursework. Students then return to the medical school for the summer and autumn semester of the fifth year, followed by a final semester at Stern.
Copyright The Financial Times Limited 2016. You may share using our article tools.
Please don't cut articles from FT.com and redistribute by email or post to the web.